vs

Side-by-side financial comparison of Copart (CPRT) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.1× Copart). Copart runs the higher net margin — 35.0% vs 21.2%, a 13.7% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 0.7%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 6.4%).

Copart, Inc. is a multinational provider of online vehicle auction and remarketing services to automotive resellers such as insurance, rental car, fleet, and finance companies in 11 countries: the US, Canada, the UK, Germany, Ireland, Brazil, Spain, UAE, Bahrain, Oman, and Finland. Headquartered in Dallas, Texas, Copart has more than 200 physical locations, where it houses more than 10,000 acres of vehicle inventory.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

CPRT vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.1× larger
DXCM
$1.3B
$1.2B
CPRT
Growing faster (revenue YoY)
DXCM
DXCM
+20.9% gap
DXCM
21.6%
0.7%
CPRT
Higher net margin
CPRT
CPRT
13.7% more per $
CPRT
35.0%
21.2%
DXCM
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
6.4%
CPRT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CPRT
CPRT
DXCM
DXCM
Revenue
$1.2B
$1.3B
Net Profit
$403.7M
$267.3M
Gross Margin
62.9%
Operating Margin
37.3%
25.6%
Net Margin
35.0%
21.2%
Revenue YoY
0.7%
21.6%
Net Profit YoY
11.5%
153.6%
EPS (diluted)
$0.41
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPRT
CPRT
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$1.2B
$1.3B
Q3 25
$1.1B
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$1.2B
$1.0B
Q4 24
$1.1B
$1.1B
Q3 24
$1.1B
$994.2M
Q2 24
$1.1B
$1.0B
Net Profit
CPRT
CPRT
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$403.7M
$267.3M
Q3 25
$396.4M
$283.8M
Q2 25
$406.6M
$179.8M
Q1 25
$387.4M
$105.4M
Q4 24
$362.1M
$151.7M
Q3 24
$322.6M
$134.6M
Q2 24
$382.3M
$143.5M
Gross Margin
CPRT
CPRT
DXCM
DXCM
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
CPRT
CPRT
DXCM
DXCM
Q1 26
25.6%
Q4 25
37.3%
25.6%
Q3 25
36.7%
20.1%
Q2 25
37.3%
18.4%
Q1 25
36.6%
12.9%
Q4 24
35.4%
17.0%
Q3 24
33.6%
15.3%
Q2 24
38.8%
15.7%
Net Margin
CPRT
CPRT
DXCM
DXCM
Q1 26
21.2%
Q4 25
35.0%
21.2%
Q3 25
35.2%
23.5%
Q2 25
33.6%
15.5%
Q1 25
33.3%
10.2%
Q4 24
31.6%
13.6%
Q3 24
30.2%
13.5%
Q2 24
33.9%
14.3%
EPS (diluted)
CPRT
CPRT
DXCM
DXCM
Q1 26
$0.67
Q4 25
$0.41
$0.67
Q3 25
$0.40
$0.70
Q2 25
$0.42
$0.45
Q1 25
$0.40
$0.27
Q4 24
$0.37
$0.37
Q3 24
$0.34
$0.34
Q2 24
$0.39
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPRT
CPRT
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$9.6B
$2.7B
Total Assets
$10.6B
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPRT
CPRT
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$917.7M
Q3 25
$1.8B
Q2 25
$1.2B
Q1 25
$904.9M
Q4 24
$606.1M
Q3 24
$621.2M
Q2 24
$939.2M
Total Debt
CPRT
CPRT
DXCM
DXCM
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$0
Q2 24
$427.0K
Stockholders' Equity
CPRT
CPRT
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$9.6B
$2.7B
Q3 25
$9.2B
$2.7B
Q2 25
$8.8B
$2.6B
Q1 25
$8.3B
$2.3B
Q4 24
$7.9B
$2.1B
Q3 24
$7.5B
$2.0B
Q2 24
$7.2B
$2.4B
Total Assets
CPRT
CPRT
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$10.6B
$6.3B
Q3 25
$10.1B
$7.5B
Q2 25
$9.7B
$7.3B
Q1 25
$9.2B
$6.8B
Q4 24
$8.9B
$6.5B
Q3 24
$8.4B
$6.4B
Q2 24
$8.0B
$6.8B
Debt / Equity
CPRT
CPRT
DXCM
DXCM
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPRT
CPRT
DXCM
DXCM
Operating Cash FlowLast quarter
$535.3M
Free Cash FlowOCF − Capex
$427.2M
FCF MarginFCF / Revenue
37.0%
Capex IntensityCapex / Revenue
9.4%
Cash ConversionOCF / Net Profit
1.33×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPRT
CPRT
DXCM
DXCM
Q1 26
Q4 25
$535.3M
$294.0M
Q3 25
$438.5M
$659.9M
Q2 25
$700.9M
$303.0M
Q1 25
$178.1M
$183.8M
Q4 24
$482.3M
$301.4M
Q3 24
$439.2M
$199.5M
Q2 24
$496.3M
$279.4M
Free Cash Flow
CPRT
CPRT
DXCM
DXCM
Q1 26
Q4 25
$427.2M
$192.1M
Q3 25
$350.8M
$579.4M
Q2 25
$572.9M
$208.9M
Q1 25
$61.5M
$96.8M
Q4 24
$245.5M
$176.8M
Q3 24
$301.3M
$88.3M
Q2 24
$408.5M
$213.3M
FCF Margin
CPRT
CPRT
DXCM
DXCM
Q1 26
Q4 25
37.0%
15.3%
Q3 25
31.2%
47.9%
Q2 25
47.3%
18.1%
Q1 25
5.3%
9.3%
Q4 24
21.4%
15.9%
Q3 24
28.2%
8.9%
Q2 24
36.2%
21.2%
Capex Intensity
CPRT
CPRT
DXCM
DXCM
Q1 26
Q4 25
9.4%
8.1%
Q3 25
7.8%
6.7%
Q2 25
10.6%
8.1%
Q1 25
10.0%
8.4%
Q4 24
20.6%
11.2%
Q3 24
12.9%
11.2%
Q2 24
7.8%
6.6%
Cash Conversion
CPRT
CPRT
DXCM
DXCM
Q1 26
Q4 25
1.33×
1.10×
Q3 25
1.11×
2.33×
Q2 25
1.72×
1.69×
Q1 25
0.46×
1.74×
Q4 24
1.33×
1.99×
Q3 24
1.36×
1.48×
Q2 24
1.30×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPRT
CPRT

Services$952.1M82%
Other$203.0M18%

DXCM
DXCM

Segment breakdown not available.

Related Comparisons